New technology for the Stellant D CT Injection System from MEDRAD is designed to improve timing for cardiac CT imaging. SmartFlow automatically suggests injection protocols by factoring in patient-specific parameters, which can be a time-consuming process if done manually.
With Smartflow, a site can select preferences such as flow rates or grams of iodine over time in advance. Reportedly, the technologist would then only need to enter a few patient-specific parameters to activate the Stellant to calculate a suggested protocol that can then be used as-is or adjusted at the user’s discretion.


Additional Content

News | Contrast Media

Oct. 27, 2026 – Bracco has announced plans to invest $230 million to establish its first U.S. manufacturing facility for ...

Time October 28, 2026
arrow
News | Cardiac Imaging

Aug. 11, 2026 — Bracco Imaging recently announced that VueJect, its dedicated ultrasound contrast delivery system ...

Time August 12, 2026
arrow
News | Contrast Agents

June 15, 2026 – Bayer has announced that the U.S. Food and Drug Administration (FDA) approved Ambelvist (gadoquatrane) ...

Time June 16, 2026
arrow
News | FDA

May 18, 2026 — ACIST Medical Systems, a Bracco company, has received U.S. Food and Drug Administration (FDA) clearance ...

Time May 18, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

March 4, 2026 — The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to Bayer for the expanded ...

Time March 04, 2026
arrow
Subscribe Now